410 related articles for article (PubMed ID: 32512768)
1. Pharmacological Treatments for Patients with Treatment-Resistant Depression.
Ruberto VL; Jha MK; Murrough JW
Pharmaceuticals (Basel); 2020 Jun; 13(6):. PubMed ID: 32512768
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
Tundo A; de Filippis R; Proietti L
World J Psychiatry; 2015 Sep; 5(3):330-41. PubMed ID: 26425446
[TBL] [Abstract][Full Text] [Related]
3. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.
Jha MK; Mathew SJ
Am J Psychiatry; 2023 Mar; 180(3):190-199. PubMed ID: 36855876
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium.
Vázquez GH; Bahji A; Undurraga J; Tondo L; Baldessarini RJ
J Psychopharmacol; 2021 Aug; 35(8):890-900. PubMed ID: 34238049
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic options for treatment-resistant depression.
Shelton RC; Osuntokun O; Heinloth AN; Corya SA
CNS Drugs; 2010 Feb; 24(2):131-61. PubMed ID: 20088620
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.
Bobo WV; Shelton RC
Expert Rev Neurother; 2010 May; 10(5):651-70. PubMed ID: 20420487
[TBL] [Abstract][Full Text] [Related]
8. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions.
McIntyre RS; Alsuwaidan M; Baune BT; Berk M; Demyttenaere K; Goldberg JF; Gorwood P; Ho R; Kasper S; Kennedy SH; Ly-Uson J; Mansur RB; McAllister-Williams RH; Murrough JW; Nemeroff CB; Nierenberg AA; Rosenblat JD; Sanacora G; Schatzberg AF; Shelton R; Stahl SM; Trivedi MH; Vieta E; Vinberg M; Williams N; Young AH; Maj M
World Psychiatry; 2023 Oct; 22(3):394-412. PubMed ID: 37713549
[TBL] [Abstract][Full Text] [Related]
9. The integrative management of treatment-resistant depression: a comprehensive review and perspectives.
Carvalho AF; Berk M; Hyphantis TN; McIntyre RS
Psychother Psychosom; 2014; 83(2):70-88. PubMed ID: 24458008
[TBL] [Abstract][Full Text] [Related]
10. Second-generation antipsychotics for major depressive disorder and dysthymia.
Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
[TBL] [Abstract][Full Text] [Related]
11. Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review.
Caldiroli A; Capuzzi E; Tagliabue I; Capellazzi M; Marcatili M; Mucci F; Colmegna F; Clerici M; Buoli M; Dakanalis A
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884874
[TBL] [Abstract][Full Text] [Related]
12. Optimized Treatment Strategy for Depressive Disorder.
Chen P
Adv Exp Med Biol; 2019; 1180():201-217. PubMed ID: 31784965
[TBL] [Abstract][Full Text] [Related]
13. Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis.
Nuñez NA; Joseph B; Pahwa M; Kumar R; Resendez MG; Prokop LJ; Veldic M; Seshadri A; Biernacka JM; Frye MA; Wang Z; Singh B
J Affect Disord; 2022 Apr; 302():385-400. PubMed ID: 34986373
[TBL] [Abstract][Full Text] [Related]
14. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach.
McIntyre RS; Filteau MJ; Martin L; Patry S; Carvalho A; Cha DS; Barakat M; Miguelez M
J Affect Disord; 2014 Mar; 156():1-7. PubMed ID: 24314926
[TBL] [Abstract][Full Text] [Related]
15. Cariprazine augmentation in patients with treatment resistant unipolar depression who failed to respond to previous atypical antipsychotic add-on. A case-series.
Pessina E; Martini A; Raffone F; Martiadis V
Front Psychiatry; 2023; 14():1299368. PubMed ID: 38090698
[TBL] [Abstract][Full Text] [Related]
16. Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression.
Scott F; Hampsey E; Gnanapragasam S; Carter B; Marwood L; Taylor RW; Emre C; Korotkova L; Martín-Dombrowski J; Cleare AJ; Young AH; Strawbridge R
J Psychopharmacol; 2023 Mar; 37(3):268-278. PubMed ID: 35861202
[TBL] [Abstract][Full Text] [Related]
17. Management of Treatment-Resistant Depression: Challenges and Strategies.
Voineskos D; Daskalakis ZJ; Blumberger DM
Neuropsychiatr Dis Treat; 2020; 16():221-234. PubMed ID: 32021216
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Strategies for Treatment-resistant Depression: State of the Art and Future Perspectives.
Goh KK; Chang SC; Chen CH; Lu ML
Curr Pharm Des; 2020; 26(2):244-252. PubMed ID: 31924151
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of augmentation strategies for patients with major depressive disorder.
Fleurence R; Williamson R; Jing Y; Kim E; Tran QV; Pikalov AS; Thase ME
Psychopharmacol Bull; 2009; 42(3):57-90. PubMed ID: 19752841
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
